In recent trading session, Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) saw 1,244,291 shares changing hands at last check today with its beta currently measuring 0. Company’s recent
Xeris Pharmaceuticals Inc. (NASDAQ:XERS) has a beta value of 0 and has seen 2,211,388 shares traded in the last trading session. The company, currently valued
In the last trading session, 2,441,776 shares of the Xeris Pharmaceuticals, Inc.(NASDAQ:XERS) were traded, and its beta was 0. Most recently the company’s share price
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS)’s traded shares stood at 1,034,790 during the last session, with the company’s beta value hitting 0. At the close of trading,
In the last trading session, 2,174,253 Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) shares changed hands as the company’s beta touched 0. With the company’s per share price
In last trading session, Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) saw 1,586,503 shares changing hands with its beta currently measuring 0. Company’s recent per share price level
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) has a beta value of 0 and has seen 969,924 shares traded in the recent trading session. The company, currently valued
During the last session, Xeris Pharmaceuticals, Inc. (NASDAQ:XERS)’s traded shares were 1,712,554, with the beta value of the company hitting 0. At the end of
In the last trading session, 1,305,479 shares of the Xeris Pharmaceuticals, Inc.(NASDAQ:XERS) were traded, and its beta was 0. Most recently the company’s share price
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS)’s traded shares stood at 1,458,075 during the last session, with the company’s beta value hitting 0. At the close of trading,